66053-10-9Relevant academic research and scientific papers
2-Aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists
Ferguson, Gemma N.,Valant, Celine,Horne, James,Figler, Heidi,Flynn, Bernard L.,Linden, Joel,Chalmers, David K.,Sexton, Patrick M.,Christopoulos, Arthur,Scammells, Peter J.
experimental part, p. 6165 - 6172 (2009/10/09)
A pharmacophore-based screen identified 32 compounds including ethyl 5-amino-3-(4-tert-butylphenyl)-4-oxo-3,4-dihydrothieno[3,4-d] pyridazine-1-carboxylate (8) as a new allosteric modulator of the adenosine A1 receptor (A1AR). On the basis of this lead, various derivatives were prepared and evaluated for activity at the human A 1AR. A number of the test compounds allosterically stabilized agonist-receptor-G protein ternary complexes in dissociation kinetic assays, but were found to be more potent as antagonists in subsequent functional assays of ERK1/2 phosphorylation. Additional experiments on the most potent antagonist, 13b, investigating A1AR-mediated [35S]GTPγS binding and [3H]CCPA equilibrium binding confirmed its antagonistic mode of action and also identified inverse agonism. This study has thus identified a new class of A1AR antagonists that can also recognize the receptor's allosteric site with lower potency.
